Innerfield I, Stone M L, Mersheimer W, Clauss R D, Greenberg J
Am J Clin Pathol. 1976 Mar;65(3):384-9. doi: 10.1093/ajcp/65.3.384.
An antithrombin assay (AA) and an antithrombin assay modified by the addition of heparin (H-AA) were performed using sera from healthy subjects, patients predisposed to thrombosis, and patients with thromboembolic disease. Characteristic AA, and H-AA patterns were found in each group. Normal controls and four of 39 "pill" patients (10%) had normal AA and H-AA findings (Pattern A). Normal AA, with "decreasing" H-AA (Pattern B) was found in sera of 31 of 39 "pill" patients (80%) and three patients who had non-embolic arterial occlusive disease. Low AA and "decreasing" H-AA (Pattern C) occurred in sera of four "pill"-takers (10%) and one patient who had an arterial embolus. Low AA and low H-AA (Pattern D) developed in sera of eight patients with thrombophlebitis and seven patients with pulmonary embolus. It is concluded that the AA and H-AA assays help to identify thrombosis-prone (Pattern C) and thrombotic (Pattern D) individuals for whom antiplatelet (aspirin; dipyridamole) or anticoagulant therapy might be beneficial.
使用健康受试者、易患血栓形成的患者以及患有血栓栓塞性疾病的患者的血清进行抗凝血酶测定(AA)和添加肝素后改良的抗凝血酶测定(H - AA)。在每组中均发现了特征性的AA和H - AA模式。正常对照组以及39名“服药”患者中的4名(10%)的AA和H - AA结果正常(模式A)。39名“服药”患者中的31名(80%)以及3名患有非栓塞性动脉闭塞性疾病的患者的血清中发现正常的AA以及“降低”的H - AA(模式B)。4名“服药”者(10%)以及1名患有动脉栓塞的患者的血清中出现低AA和“降低”的H - AA(模式C)。8名血栓性静脉炎患者和7名肺栓塞患者的血清中出现低AA和低H - AA(模式D)。得出的结论是,AA和H - AA测定有助于识别可能从抗血小板(阿司匹林;双嘧达莫)或抗凝治疗中获益的易形成血栓(模式C)和血栓形成(模式D)的个体。